Search results
FIXa Controls (ultra low)
Factor IXa controls are intended for the quality control of activated factor IX (FIXa) chromogenic measurements (approx. 1.3 mlU/mL), using BIOPHEN® Factor IXa assay (ref. 221812).
FIXa Controls (ultra low)
Factor IXa controls are intended for the quality control of activated factor IX (FIXa) chromogenic measurements (approx. 0.2 mIU/mL), using BIOPHEN Factor IXa assay (ref. 221812).
FIXa Calibrator
Lyophilized plasma for the calibration of factor IXa measurements using the chromogenic assays and especially BIOPHEN Factor IXa assay (ref. 221812).
FIX Inhibitor Plasma (1) mild (1-10 BU/ml), lyophilized
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FIX Inhibitor Plasma (1) mild (1-10 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FII Inhibitor Plasma (1) mild (1-10 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FIBRIPHEN™ LRT
Clotting method for quantitative determination of fibrinogen (Clauss method)
Events
Epinephrine
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
Emicizumab Controls
Quality control of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.